Talon Therapeutics, Inc.·4

Dec 23, 4:07 PM ET

NIELSEN TYLER MARSHALL 4

4 · Talon Therapeutics, Inc. · Filed Dec 23, 2010

Insider Transaction Report

Form 4
Period: 2010-12-21
Transactions
  • Award

    Stock Option (right to buy)

    2010-12-21+67,50067,500 total
    Exercise: $0.49Exp: 2020-12-21Common Stock (67,500 underlying)
Holdings
  • Common Stock

    399
  • Stock Option (right to buy)

    Exercise: $4.48Exp: 2017-12-14Common Stock (12,500 underlying)
    12,500
  • Stock Option (right to buy)

    Exercise: $0.56Exp: 2019-02-24Common Stock (6,250 underlying)
    6,250
  • Common Stock

    (indirect: By Spouse)
    25
  • Stock Option (right to buy)

    Exercise: $28.44Exp: 2016-02-22Common Stock (7,500 underlying)
    7,500
  • Stock Option (right to buy)

    Exercise: $0.76Exp: 2020-02-16Common Stock (10,000 underlying)
    10,000
  • Stock Option (right to buy)

    Exercise: $27.28Exp: 2016-12-12Common Stock (16,250 underlying)
    16,250
  • Stock Option (right to buy)

    Exercise: $6.64Exp: 2017-06-25Common Stock (6,250 underlying)
    6,250
Footnotes (5)
  • [F1]On 9/10/10, the Company completed a one-for-four reverse stock split. All common stock amounts and exercise prices in the filing relating to securities acquired prior to 9/10/10 have been adjusted to reflect the one-for-four reverse stock split.
  • [F2]100% vested
  • [F3]2,083 shares vest on each of 2/24/10 and 2/24/11; 8,334 shares vest on 2/24/12.
  • [F4]One-third of the shares vest on 2/16/11 and the remaining two-thirds vest in 24 equal monthly installments thereafter.
  • [F5]Shares vest in 48 equal monthly installments beginning 1/21/11.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT